These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20185249)

  • 21. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulated PAR-2 is associated in part with interrupted melanosome transfer in pigmented basal cell epithelioma.
    Sakuraba K; Hayashi N; Kawashima M; Imokawa G
    Pigment Cell Res; 2004 Aug; 17(4):371-8. PubMed ID: 15250939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of erythroid differentiation regulator 1 as a novel marker of skin tumors.
    Lee YB; Kim HJ; Jung HY; Park YG; Kim SY; Cho BK; Cho D; Park HJ
    Int J Dermatol; 2014 Jun; 53(6):723-30. PubMed ID: 24168163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The roles of vitamin D in seborrhoeic keratosis: possible genetic and cellular signalling mechanisms.
    Lu'o'ng Kv; Nguyễn LT
    Int J Cosmet Sci; 2013 Dec; 35(6):525-31. PubMed ID: 23859137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
    Gaballah MA; Ahmed RA
    Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GLTSCR2 sensitizes cells to hypoxic injury without involvement of mitochondrial apoptotic cascades.
    Yim JH; Kim YJ; Cho YE; Ko JH; Kim SM; Kim JY; Park JH
    Pathobiology; 2007; 74(5):301-8. PubMed ID: 17890897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of pituitary tumor transforming gene 1 in psoriasis, seborrheic keratosis, and skin tumors.
    Cai SQ; Dou TT; Li W; Li SQ; Chen JQ; Zhou J; Zheng M; Man XY
    Discov Med; 2014 Dec; 18(101):289-99. PubMed ID: 25549700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Mast Cell-SCF-CB1 Interaction Is a Key Player in Seborrheic Keratosis.
    Yamanaka-Takaichi M; Sugawara K; Sumitomo R; Tsuruta D
    J Histochem Cytochem; 2020 Jul; 68(7):461-471. PubMed ID: 32578480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-band EPR Spectroscopic Investigation of Seborrheic Keratosis.
    Nakagawa K; Minakawa S; Sawamura D
    Anal Sci; 2019 Sep; 35(9):1027-1030. PubMed ID: 31155544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation.
    Okahara F; Itoh K; Nakagawara A; Murakami M; Kanaho Y; Maehama T
    Mol Biol Cell; 2006 Nov; 17(11):4888-95. PubMed ID: 16971513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression level of homocitrulline is correlated with seborrheic keratosis and skin aging.
    Chen J; Liu J; Wang Z; Xu J; Tao J; Li H
    An Bras Dermatol; 2023; 98(3):324-330. PubMed ID: 36610814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic basis of seborrheic keratosis and epidermal nevi].
    Hafner C; Hafner H; Groesser L
    Pathologe; 2014 Sep; 35(5):413-23. PubMed ID: 25187080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of epidermal growth factor receptor in patients with insulin resistance and seborrheic keratomas].
    Smolyannikova VA; Alexandrova AK
    Arkh Patol; 2017; 79(4):18-21. PubMed ID: 28791994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low incidence of oncogenic EGFR, HRAS, and KRAS mutations in seborrheic keratosis.
    Georgieva IA; Mauerer A; Groesser L; Herschberger E; Aslanidis C; Dietmaier W; Landthaler M; Hafner C
    Am J Dermatopathol; 2014 Aug; 36(8):635-42. PubMed ID: 23739246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple epithelial cytokeratin-expression in seborrheic keratosis.
    Nindl M; Nakagawa H; Furue M; Ishibashi Y
    J Cutan Pathol; 1992 Oct; 19(5):415-22. PubMed ID: 1282137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans.
    Hiraishi Y; Hirobe S; Iioka H; Quan YS; Kamiyama F; Asada H; Okada N; Nakagawa S
    J Control Release; 2013 Oct; 171(2):93-103. PubMed ID: 23791975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous malignancies simulating seborrheic keratoses: An underappreciated phenomenon?
    Chen TY; Morrison AO; Cockerell CJ
    J Cutan Pathol; 2017 Sep; 44(9):747-748. PubMed ID: 28589622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of immunosuppression in squamous cell carcinomas arising in seborrheic keratosis.
    Conic RZ; Napekoski K; Schuetz H; Piliang M; Bergfeld W; Atanaskova Mesinkovska N
    J Am Acad Dermatol; 2017 Jun; 76(6):1146-1150. PubMed ID: 28162852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of endothelin-1 in hyperpigmentation in seborrhoeic keratosis.
    Teraki E; Tajima S; Manaka I; Kawashima M; Miyagishi M; Imokawa G
    Br J Dermatol; 1996 Dec; 135(6):918-23. PubMed ID: 8977712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.